Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
View graph of relations

Research areas

Clinical research in diabetic complications, main focus on diabetic nephropathy and cardiovascular disease

clinical trials, biomarker discovery with targeted and untargeted methods

metabolomics in relation to progresion of type 1 and type 2 diabetes, liver disease and diabetic complications

Main research areas

Diabetic nephropathy, cardiovascular disease, neuropathy, metabolomics

Current research

Focus on late diabetic complications,

biomarkers predicting risk for initiation or progression of complications,

clinical studies of interventions aiming at preventing or treating complications

improving understanding of pathophysiology of complications

Potential conflicts of interest

•consultancy and/or speaking fees (to institution) from AbbVie, Astellas, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Eli Lilly, MSD, Novo Nordisk and Sanofi Aventis
•research grants from AstraZeneca and Novo Nordisk
shares in Novo Nordisk

ID: 50137657